Profile
Sara Sande is currently Director at Biosyntia ApS, Independent Director at Expres2ion Biotech Holding AB since 2021, Director at ExpreS2ion Biotechnologies ApS, Director at Agreena ApS, Director at Monta ApS, Vice President at Origio A, and Partner at Danmarks Eksport- og Investeringsfond.
Former positions include Independent Director at Hydract A, Head-Grain & Beverages Sales at Novozymes A, and Vice President-Global Commercial Development at CooperSurgical, Inc. Education includes a graduate degree from the University of Copenhagen conferred in 2002.
Sara Sande active positions
| Companies | Position | Start |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Director/Board Member | 26/05/2021 |
Origio A/S
Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Corporate Officer/Principal | - |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Director/Board Member | - |
Agreena ApS
Agreena ApS Packaged SoftwareTechnology Services Operates as an agricultural technology company that offers soil carbon platform | Director/Board Member | - |
Monta ApS
Monta ApS Packaged SoftwareTechnology Services Provides EV ecosystem software solutions | Director/Board Member | - |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Director/Board Member | - |
Danmarks Eksport- og Investeringsfond
Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Private Equity Investor | - |
Former positions of Sara Sande
| Companies | Position | End |
|---|---|---|
CooperSurgical, Inc.
CooperSurgical, Inc. Medical SpecialtiesHealth Technology Produces and markets medical devices for fertility & women's health care | Corporate Officer/Principal | - |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Sara Sande
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
CooperSurgical, Inc.
CooperSurgical, Inc. Medical SpecialtiesHealth Technology Produces and markets medical devices for fertility & women's health care | Health Technology |
Danmarks Eksport- og Investeringsfond
Danmarks Eksport- og Investeringsfond Investment ManagersFinance EIFO invests in small and medium-sized companies located in Denmark. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and debt with an investment size of DKK 5 - 200 million. It also takes a seat on the board of directors. | Finance |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origio A/S
Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Provides services in synthetic biology and metabolic engineering fields | Health Technology |
Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Hydract A/S
Hydract A/S Industrial MachineryProducer Manufacturing Develops and manufactures water-hydraulic process valves and actuators for the food, beverage, dairy and pharmaceutical industries | Producer Manufacturing |
Agreena ApS
Agreena ApS Packaged SoftwareTechnology Services Operates as an agricultural technology company that offers soil carbon platform | Technology Services |
Monta ApS
Monta ApS Packaged SoftwareTechnology Services Provides EV ecosystem software solutions | Technology Services |
- Stock Market
- Insiders
- Sara Sande
















